Literature DB >> 9521082

Imaging antigen recognition by naive CD4+ T cells: compulsory cytoskeletal alterations for the triggering of an intracellular calcium response.

J Delon1, N Bercovici, R Liblau, A Trautmann.   

Abstract

Antigen recognition was analyzed at the single-cell level by using for the first time T cells which were not altered by in vitro selection, transfection or immortalization. The first consequence of antigen recognition by ex vivo naive CD4+ T cells from T cell receptor (TCR)-transgenic mice is the formation of a "contact zone" with the B cell presenting the antigen. The T cell intracellular calcium (Ca2+) response begins after a delay of 30 s on average, following the formation of the contact zone. The T cell response is entirely inhibited by either protein tyrosine kinase or actin polymerization inhibitors but, surprisingly, it is insensitive to inhibitors of phosphoinositide 3-kinase. Moreover, inhibition of microtubule polymerization and use of Ca2+-free medium do not prevent the beginning of the T cell response, but do reduce the stability of the contact zone and/or the amplitude of the Ca2+ plateau. The critical involvement of the cytoskeleton in antigen recognition on B cells introduces a checkpoint in T cell activation: the initial TCR engagement triggers a Ca2+ response only after an amplification step corresponding to a cytoskeleton-controlled increase in the number of engaged TCR.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9521082     DOI: 10.1002/(SICI)1521-4141(199802)28:02<716::AID-IMMU716>3.0.CO;2-E

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  33 in total

1.  Anergy in CD4 memory T lymphocytes. II. Abrogation of TCR-induced formation of membrane signaling complexes.

Authors:  William T Lee; Aparna Prasad; Andrew R O Watson
Journal:  Cell Immunol       Date:  2012-05-19       Impact factor: 4.868

2.  The actin cytoskeleton and cytotoxic T lymphocytes: evidence for multiple roles that could affect granule exocytosis-dependent target cell killing.

Authors:  Taras A Lyubchenko; Georjeana A Wurth; Adam Zweifach
Journal:  J Physiol       Date:  2003-02-07       Impact factor: 5.182

3.  Vav1 dephosphorylation by the tyrosine phosphatase SHP-1 as a mechanism for inhibition of cellular cytotoxicity.

Authors:  Christopher C Stebbins; Carsten Watzl; Daniel D Billadeau; Paul J Leibson; Deborah N Burshtyn; Eric O Long
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

Review 4.  Diversity in immunological synapse structure.

Authors:  Timothy J Thauland; David C Parker
Journal:  Immunology       Date:  2010-10-29       Impact factor: 7.397

5.  Actin-bundling protein L-plastin regulates T cell activation.

Authors:  Chen Wang; Sharon Celeste Morley; David Donermeyer; Ivan Peng; Wyne P Lee; Jason Devoss; Dimitry M Danilenko; Zhonghua Lin; Juan Zhang; Jie Zhou; Paul M Allen; Eric J Brown
Journal:  J Immunol       Date:  2010-11-12       Impact factor: 5.422

6.  Cortical Actin Flow in T Cells Quantified by Spatio-temporal Image Correlation Spectroscopy of Structured Illumination Microscopy Data.

Authors:  George Ashdown; Elvis Pandžić; Andrew Cope; Paul Wiseman; Dylan Owen
Journal:  J Vis Exp       Date:  2015-12-17       Impact factor: 1.355

7.  Actin depolymerization transduces the strength of B-cell receptor stimulation.

Authors:  Shengli Hao; Avery August
Journal:  Mol Biol Cell       Date:  2005-02-23       Impact factor: 4.138

Review 8.  RHO GTPases: from new partners to complex immune syndromes.

Authors:  Rana El Masri; Jérôme Delon
Journal:  Nat Rev Immunol       Date:  2021-02-05       Impact factor: 53.106

Review 9.  T cell receptor signalling networks: branched, diversified and bounded.

Authors:  Rebecca J Brownlie; Rose Zamoyska
Journal:  Nat Rev Immunol       Date:  2013-04       Impact factor: 53.106

Review 10.  Coordinate control of cytoskeletal remodeling and calcium mobilization during T-cell activation.

Authors:  Alexander Babich; Janis K Burkhardt
Journal:  Immunol Rev       Date:  2013-11       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.